These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 841576)

  • 1. Phenobarbital-induced drug metabolism in man.
    Kellermann G; Luyten-Kellermann M
    Toxicol Appl Pharmacol; 1977 Jan; 39(1):97-104. PubMed ID: 841576
    [No Abstract]   [Full Text] [Related]  

  • 2. Elimination of antipyrine and benzo[a]pyrene metabolism in cultured human lymphocytes.
    Kellermann G; Luyten-Kellermann M; Horning MG; Stafford M
    Clin Pharmacol Ther; 1976 Jul; 20(1):72-80. PubMed ID: 1277727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-pressure liquid chromatographic analysis of benzo(a)pyrene metabolism by human lymphocytes from donors of different aryl hydrocarbon hydroxylase inducibility and antipyrine half-lives.
    Gurtoo HL; Vaught JB; Marinello AJ; Paigen B; Gessner T; Bolanowska W
    Cancer Res; 1980 Apr; 40(4):1305-10. PubMed ID: 7357559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expanding role of microsomal enzyme induction, and its implications for clinical chemistry.
    Goldberg DM
    Clin Chem; 1980 May; 26(6):691-9. PubMed ID: 6989516
    [No Abstract]   [Full Text] [Related]  

  • 5. Correlation of aryl hydrocarbon hydroxylase activity of human lymphocyte cultures and plasma elimination rates for antipyrine and phenylbutazone.
    Kellermann G; Luyten-Kellermann M; Horning M; Stafford M
    Drug Metab Dispos; 1975; 3(1):47-50. PubMed ID: 234834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic control of interindividual variations in the inducibility of aryl hydrocarbon hydroxylase in cultured human lymphocytes.
    Atlas SA; Vesell ES; Nebert DW
    Cancer Res; 1976 Dec; 36(12):4619-30. PubMed ID: 63323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-dependent enzyme induction.
    Breckenridge A; Davies DS; Davies L; Orme M
    Br J Pharmacol; 1973 Mar; 47(3):616P-617P. PubMed ID: 4730838
    [No Abstract]   [Full Text] [Related]  

  • 8. Genetic control of the phenobarbital-induced shortening of plasma antipyrine half-lives in man.
    Vesell ES; Page JG
    J Clin Invest; 1969 Dec; 48(12):2202-9. PubMed ID: 5389794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of phenobarbital steady state levels on antipyrine clearance and distribution in the rat.
    Pei YY; Bialer M; Levy RH
    Biopharm Drug Dispos; 1986; 7(1):11-9. PubMed ID: 3955196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme induction in sheep: effects of phenobarbital on in vivo and in vitro drug metabolism.
    Shetty SN; Himes JA; Edds GT
    Am J Vet Res; 1972 May; 33(5):935-42. PubMed ID: 4112405
    [No Abstract]   [Full Text] [Related]  

  • 11. 14C-antipyrine as a model compound in the study of drug oxidation and enzyme induction in individual surviving rats.
    Bakke OM; Bending M; Aarbakke J; Davies DS
    Acta Pharmacol Toxicol (Copenh); 1974 Aug; 35(2):91-7. PubMed ID: 4479350
    [No Abstract]   [Full Text] [Related]  

  • 12. Oxidative drug metabolism and inducibility by phenobarbital in sickle cell anemia.
    Anderson KE; Peterson CM; Alvares AP; Kappas A
    Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):580-7. PubMed ID: 913026
    [No Abstract]   [Full Text] [Related]  

  • 13. The metabolism of phenobarbitone, phenytoin and antipyrine in Black patients.
    Buchanan N; Bill P; Moodley G; Eyberg C
    S Afr Med J; 1977 Aug; 52(10):394-5. PubMed ID: 897846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship of host factors to the pathogenesis of chronic bronchitis and obstructive airway disease: lymphoblast aryl hydrocarbon hydroxylase.
    Naseem SM; Tishler PV; Tager IB; Rosner B; Speizer FE
    Am Rev Respir Dis; 1978 Apr; 117(4):647-55. PubMed ID: 646217
    [No Abstract]   [Full Text] [Related]  

  • 15. The plasma half-life of antipyrine in chromic uraemic and normal subjects.
    Maddocks JL; Wake CJ; Harber MJ
    Br J Clin Pharmacol; 1975 Aug; 2(4):339-43. PubMed ID: 1233993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aryl hydrocarbon hydroxylase in intact human mitogen-stimulated lymphocytes. Laboratory, environmental and genetic factors influencing activity and inducibility of the enzyme.
    Pawlak AL; Mikstacka RM
    Acta Med Pol; 1979; 20(4):347-52. PubMed ID: 575699
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of drug pretreatment on antipyrine levels in blood and tissues: an example of multiple drug interactions.
    Sotaniemi EA
    Pharmacology; 1973; 10(5):306-16. PubMed ID: 4764537
    [No Abstract]   [Full Text] [Related]  

  • 18. Absence of seasonal variation in antipyrine metabolism.
    Paigen B; Ward E; Steenland K; Bolanowska W; Gessner T; Chang RL; Wood AW; Conney AH
    Clin Pharmacol Ther; 1982 Feb; 31(2):144-50. PubMed ID: 7056021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of antipyrine and phenobarbital on renal gamma-glutamyltransferase excretion in human urine.
    Wensing G; Neumann U; Ohnhaus EE; Heidemann HT
    Clin Pharmacol Ther; 1990 Nov; 48(5):575-81. PubMed ID: 1977543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.
    Branch RA; Shand DG; Wilkinson GR; Nies AS
    J Clin Invest; 1974 Apr; 53(4):1101-7. PubMed ID: 4205524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.